📰 Philipp Harter News
Philipp Harter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Philipp Harter. Real-time updates on events, politics, business and more.
August 2, 2023
Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded.
June 5, 2023
Positive findings in patients with advanced high-grade epithelial ovarian cancer were presented during an oral presentation at the 2023 American Society of Clinical Oncology Annual Meeting.
June 3, 2023
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
April 11, 2023
Individuals treated with the drugs from AstraZeneca demonstrate clinically meaningful and statistically significant improvement.
April 5, 2023
Positive high-level results from a planned interim analysis of the DUO-O Phase III trial showed treatment with a combination of Lynparza (olaparib
April 5, 2023
Induction therapy with durvalumab plus chemotherapy and bevacizumab, followed by maintenance with olaparib plus durvalumab and bevacizumab, elicited a statistically significant and clinically meaningful improvement in progression-free survival compared with chemotherapy plus bevacizumab in patients with newly diagnosed advanced high-grade epithelial ovarian cancer who did not harbor BRCA mutations.
December 3, 2021
The most favorable outcome was seen for patients with a complete resection, with a median overall survival of 61.9 months.